Butrans for Treatment of Restless Legs Syndrome

Trial Profile

Butrans for Treatment of Restless Legs Syndrome

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2015

At a glance

  • Drugs Buprenorphine (Primary)
  • Indications Restless legs syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jan 2015 Status changed from not yet recruiting to withdrawn prior to enrolment, according to ClinicalTrials.gov record.
    • 19 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top